<table id="ID83" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="35%"></col>
<col width="65%"></col>
<tbody>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">
<content stylecode="bold">Interacting </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">
<content stylecode="bold">Interaction</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Multivalent cation-containing products including: antacids, sucralfate, multivitamins<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Decreased moxifloxacin absorption. Take moxifloxacin hydrochloride tablet at least 4 hours before or 8 hours after these products. (2.2, 7.1, 12.3)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Warfarin<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Anticoagulant effect enhanced. Monitor prothrombin time/INR, and bleeding. (6, 7.2, 12.3)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Class IA and Class III antiarrhythmics:<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Proarrhythmic effect may be enhanced. Avoid concomitant use. (5.6, 7.5)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Antidiabetic agents<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="middle">Carefully monitor blood glucose. (5.11, 7.3)<br/>
</td>
</tr>
</tbody>
</table>